Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
EARLY_PHASE1
15
about 1.7 years
18+
2 sites in PA
What this study is about
Researchers are testing a treatment called Fluciclovine F18 to see how it affects glioblastoma tumors. The trial will compare the results from imaging tests like PET scans and advanced MRIs with lab tests on tumor tissue to understand how these tumors use energy (glucose, lactate) and amino acids (glutamine/glutamate).
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Fluciclovine F18
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Diagnostic Agent (Positron Emitting Activity)
Primary: Uptake Values (SUV)
Neurology, Oncology